<DOC>
	<DOCNO>NCT02819648</DOCNO>
	<brief_summary>The aim single-center randomize , double-blind , placebo-controlled clinical trial ass effect preoperative , single , oral dose prednisolone postoperative pain medication intake patient symptomatic , irreversible pulpitis mandibular molar .</brief_summary>
	<brief_title>Oral Glucocorticoids Effect Post Endodontic Pain</brief_title>
	<detailed_description>Patients receive 40 mg prednisolone ( two tablet Prednisolone 20 mg , Aventis Intercontinental , Paris , France ) ; group B ( Control ) , patient receive two placebo tablet . All patient receive assign premedication 30 minute administration local anesthesia</detailed_description>
	<mesh_term>Pulpitis</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<criteria>Systemically healthy patient , age 1835 year , mandibular molar symptomatic irreversible pulpitis , radiographicallynormal periapical area pain bite percussion . Pregnant patient , patient know sensitivity adverse reaction medication material use study , use analgesic medication precede 6 hour treatment , unrestorable teeth teeth severe periodontal disease . Patients active site pathosis area injection , also , exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>symptomatic</keyword>
	<keyword>irreversible</keyword>
</DOC>